Printer Friendly

CTI Clinical Trial/Consulting Acquires Portugal-Based CRO Eurotrials.

M2 EQUITYBITES-December 15, 2017-CTI Clinical Trial/Consulting Acquires Portugal-Based CRO Eurotrials


15 December 2017 - Ohio, US-based contract research organisation (CRO) CTI Clinical Trial and Consulting Services has acquired Portugal-based full-service CRO Eurotrials to strengthen CTI's presence and expertise in Europe and Latin America, the company said.

The terms of the acquisition were not disclosed.

Eurotrials has offices in Argentina, Brazil, Chile, Mexico, Peru, Portugal and Spain, covering over 15 countries in both regions.

Eurotrials provides services from early- to late-stage research as well as product support in accordance with global and specific regional requirements.

Additionally, the Eurotrials footprint augments CTI's current reach, enabling CTI to better serve clients and global programs.

CTI said this combined company will have associates in more than 30 countries across six continents.

CTI Clinical Trial and Consulting Services delivers a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialisation, including real world evidence.

The company's therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hematology, cardiopulmonary, and pediatric populations.

CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials.

Plante Moran and Fifth Third Bank provided support to CTI throughout the acquisition.

((Comments on this story may be sent to

COPYRIGHT 2017 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Geographic Code:4EUPR
Date:Dec 15, 2017
Previous Article:Ezcorp 21 BazareA[+ or -]o Pawn to Strengthen Position in Northwest Mexico.
Next Article:CallidusCloud Acquires Australia's Learning Seat for USD 26m.

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters